Effects of sodium taurocholate on the absorption of inhaled 99mTc-DTPA

Pharmaceutical Research

Volumn 23, Issue 9, 2006, Pages 2122-2128

  Bondesson, Eva ^a,b   Bengtsson, Thomas ^a   Nilsson, Lars Erik ^b   Wollmer, Per ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Aerosol; Lung deposition; Mucociliary clearance; Pharmacokinetics; Pulmonary drug absorption enhancement

Indexed keywords

PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TAUROCHOLIC ACID;

ADULT; ARTICLE; BIOAVAILABILITY; HALF LIFE TIME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG; MALE; METABOLISM; MIDDLE AGED; NEBULIZER; QUALITY CONTROL; SCINTISCANNING; THORAX;

ADMINISTRATION, INHALATION; ADULT; BIOLOGICAL AVAILABILITY; HALF-LIFE; HUMANS; LUNG; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; QUALITY CONTROL; RADIOPHARMACEUTICALS; TAUROCHOLIC ACID; TECHNETIUM TC 99M PENTETATE; THORAX;

EID: 33750581378     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9013-6     Document Type: Article

References (25)

1. J. G. Jones, P. Lawler, J. C. W. Crawley, B. D. Minty, G. Hulands, and N. Veall. Increased alveolar epithelial permeability in cigarette smokers. Lancet 1:66-68 (1980).
2. m]DTPA: effects of ventilation pattern. Clin. Physiol. 10:189-199 (1990).
3. B. Schmekel, L. Borgström, and P. Wollmer. Difference in pulmonary absorption of inhaled terbutaline in healthy smokers and non-smokers. Thorax 46:225-228 (1991).
4. B. Schmekel, L. Borgström, and P. Wollmer. Exercise increases the rate of pulmonary absorption of inhaled terbutaline. Chest 101:742-745 (1992).
5. 99mTc-DTPA in smokers. Clin. Physiol. 14:547-559 (1994).
6. B. Hanel, I. Law, and J. Mortensen. Maximal rowing has an acute effect on the blood-gas barrier in elite athletes. J. Appl. Physiol. 95:1076-1082 (2003).
7. A. Himmelmann, J. Jendle, A. Mellén, A. H. Petersen, U. L. Dahl, and P. Wollmer. The impact of smoking on inhaled insulin. Diabetes Care 26:677-682 (2003).
8. 99mTc-DTPA induced by detergent aerosol. J. Appl. Physiol. 77:190-196 (1994).
9. P. Wollmer, K. Bäckström, H. Zhao, P.-G. Nilsson, and B. Jonson. Surface active agents as enhancers of alveolar absorption. Pharm. Res. 17:38-41 (2000).
10. M. Dahlbäck, S. Eirefelt, K. Bäckström, P. Larsson, L.-O. Almér, P. Wollmer, and B. Jonson. Enhanced insulin absorption in the rabbit airways and lung by sodium dioctyl sulfosuccinate. J. Aerosol Med. 15:27-36 (2002).
11. L. Heinemann, T. Traut, and T. Heise. Time-action profile of inhaled insulin. Diabetic Med. 14:63-72 (1997).
12. L. Heinemann, W. Klappoth, K. Rave, B. Hompesch, R. Linkeschowa, and T. Heise. Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer. Diabetes Care 23:1343-1347 (2000).
13. 99mTc DTPA from guinea pig nasal, tracheobronchial, and bronchoalveolar airways. Thorax 45:841-845 (1990).
14. E. Bondesson, T. Bengtsson, L.-E. Nilsson, and P. Wollmer. Site of deposition and absorption of hydrophilic solutes. Submitted to Br. J. Clin. Pharmacol.
15. P. H. Quanjer (ed.) Standardized lung function testing. Report working party standardisation of lung function tests, European Community for Coal and Steel. Bull. Eur. Physiopathol. Respir. 19(suppl. 5):1-95 (1983).
16. European Pharmacopoeia, 4th ed. 2002. Section 2.9.18, 209-219.
17. D. J. Macey and R. Marshall. Absolute quantitation of radiotracer uptake in the lungs using a gamma camera. J. Nucl. Med. 23:731-735 (1982).
18. L. Olséni, J. Palmer, and P. Wollmer. Quantitative evaluation of aerosol deposition pattern in the lung in patients with chronic bronchitis. Physiol. Meas. 15:41-48 (1994).
19. E. Bondesson, L. Asking, L. Borgström, L.-E. Nilsson, E. Trofast, and P. Wollmer. In vitro and in vivo aspects of quantifying intrapulmonary deposition of a dry powder radioaerosol. Int. J. Pharm. 232:149-156 (2002).
20. F. Johansson, E. Hjertberg, S. Eirefelt, A. Tronde, and U. H. Bengtsson. Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate. Eur. J. Pharm. Sci. 17:63-71 (2002).
21. 99m Tc-DTPA: effects of surfactant depletion by lung lavage. J. Appl. Physiol. 62:1611-1614 (1987).
22. 99mTc-DTPA, lung surfactant and lung injury: a review of the literature. Appl. Cardiopulm. Pathophysiol. 4:155-160 (1991).
23. 99m Tc-DTPA and experimentally increased alveolar surfactant content. J. Appl. Physiol. 72:1413-1417 (1992).
24. 99mTc-DTPA in experimental surfactant dysfunction treated with surfactant instillation. Acta Anaesthesiol. Scand. 41:297-303 (1997).
25. G. A. Brunner, B. Balent, M. Ellmerer, L. Schaupp, A. Siebenhofer, J. H. Jendle, J. Okikawa, and T. R. Pieber. Dose-response relation of liquid aerosol inhaled insulin in Type I diabetic patients. Diabetologia 44:305-308 (2001).